Mapping the Translational Potential of Injectable Natural-Product Drug-Delivery Systems for Osteoarthritis Toward Pharmacopuncture: A Scoping Review Protocol

Background: Osteoarthritis (OA) management remains largely symptomatic, and natural products with anti-inflammatory and chondroprotective activity are limited in practice by poor joint retention and bioavailability. Pharmacopuncture, a Korean medicine treatment that injects herbal or natural-product-derived agents at acupoints or lesion sites, including the joint cavity, is a potential local delivery route, but its drug-delivery properties have not been systematically evaluated. Coupling drug-delivery system (DDS) technology with pharmacopuncture may extend joint retention and control release, yet this preclinical evidence base has not been mapped. Methods: This article reports the protocol and translational classification framework of a scoping review of preclinical studies on injectable, intra-articular, natural-product-based DDS for OA. The review followed the Joanna Briggs Institute methodology and is reported according to PRISMA-ScR. Three databases were searched on April 7, 2026. Eligible studies used an OA model (animal, in vitro, or ex vivo) and a natural product formulated within a DDS; in vivo studies also required confirmed intra-articular administration. Screening, eligibility assessment, and data extraction were each performed independently by two reviewers, with disagreements resolved by consensus. We developed a three-tier pharmacopuncture-applicability classification (Very High/High/Moderate) based on injectability, intra-articular administration, and demonstrated delivery performance. Results: Of the 667 records identified, 33 studies met all eligibility criteria after title/abstract screening and full-text assessment. Conclusion: This protocol provides a reproducible framework, including a novel translational applicability tier system, for mapping how injectable natural product DDS research for OA can inform pharmacopuncture formulation development. The findings are reported in a companion article.

Authors

Institutions

Publication Details

Journal
Journal of Acupuncture Research
Published
2026-11-16
DOI
https://doi.org/10.13045/jar.26.0050
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mapping the Translational Potential of Injectable Natural-Product Drug-Delivery Systems for Osteoarthritis Toward Pharmacopuncture: A Scoping Review Protocol

Ho Sueb Song, Aejin Song
2 links
Journal of Acupuncture Research
Osteoarthritis Treatment and Mechanisms
article

Mapping the Translational Potential of Injectable Natural-Product Drug-Delivery Systems for Osteoarthritis Toward Pharmacopuncture: A Scoping Review Protocol

Ho Sueb Song, Aejin Song
article en

Abstract

Background: Osteoarthritis (OA) management remains largely symptomatic, and natural products with anti-inflammatory and chondroprotective activity are limited in practice by poor joint retention and bioavailability. Pharmacopuncture, a Korean medicine treatment that injects herbal or natural-product-derived agents at acupoints or lesion sites, including the joint cavity, is a potential local delivery route, but its drug-delivery properties have not been systematically evaluated. Coupling drug-delivery system (DDS) technology with pharmacopuncture may extend joint retention and control release, yet this preclinical evidence base has not been mapped. Methods: This article reports the protocol and translational classification framework of a scoping review of preclinical studies on injectable, intra-articular, natural-product-based DDS for OA. The review followed the Joanna Briggs Institute methodology and is reported according to PRISMA-ScR. Three databases were searched on April 7, 2026. Eligible studies used an OA model (animal, in vitro, or ex vivo) and a natural product formulated within a DDS; in vivo studies also required confirmed intra-articular administration. Screening, eligibility assessment, and data extraction were each performed independently by two reviewers, with disagreements resolved by consensus. We developed a three-tier pharmacopuncture-applicability classification (Very High/High/Moderate) based on injectability, intra-articular administration, and demonstrated delivery performance. Results: Of the 667 records identified, 33 studies met all eligibility criteria after title/abstract screening and full-text assessment. Conclusion: This protocol provides a reproducible framework, including a novel translational applicability tier system, for mapping how injectable natural product DDS research for OA can inform pharmacopuncture formulation development. The findings are reported in a companion article.

Journal of Acupuncture ResearchVol. 43
Gachon University (KR)
National Research Foundation of Korea, Ministry of Science and ICT, South Korea
Good health and well-being
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon